Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Mycobacterium ulcerans
89%
Surgical Infection
86%
Antibiotics
75%
Buruli Ulcer
71%
Staphylococcus Aureus
61%
Disease
46%
Hospital Infection
41%
Rifampicin
38%
Streptomycin
37%
Escherichia coli
36%
Wound
33%
Infectious Agent
32%
Aminoglycoside
32%
Antimicrobial Agent
30%
Gram Negative Bacterium
28%
Ototoxicity
28%
Pseudomonas aeruginosa
28%
Minimum Inhibitory Concentration
28%
Mycobacterium Tuberculosis
28%
HIV
28%
Medicinal Plant
28%
Infection
23%
Acid Fast Bacterium
22%
Hearing Impairment
22%
Ranitidine
22%
Ammonium Sulfate
22%
Phenol
22%
Phytochemical
16%
Multidrug Resistance
14%
Community Acquired Infection
12%
Azithromycin
11%
Chronic Wound
11%
Agar
11%
Antibiotic Resistance
9%
Isoniazid Plus Pyrazinamide Plus Rifampicin
9%
Ethambutol
9%
Cetylpyridinium Salt
9%
Antibiotic Therapy
9%
Table Salt
9%
Penicillin Derivative
8%
Adicillin
8%
Antiinfective Agent
7%
Antibiotic Prophylaxis
5%
Meticillin
5%
Hypochlorite Sodium
5%
Acinetobacter Baumannii
5%
Cohort Study
5%
Agar Dilution
5%
Salmonella Enterica Serovar Typhi
5%
Nursing and Health Professions
Teaching Hospital
63%
Surgical Infection
63%
Ranitidine
56%
Prevalence
42%
Aminoglycoside
37%
Rifampicin
37%
Buruli Ulcer
32%
Prospective Cohort Study
31%
Surgical Equipment
28%
Abdominal Surgery
28%
Ototoxicity
28%
Operating Room
28%
Human Immunodeficiency Virus
28%
Decontamination
28%
Streptomycin
28%
Surgical Technique
26%
Hearing Impairment
22%
Community Acquired Infection
18%
Adicillin
18%
Penicillin Derivative
18%
Antiinfective Agent
16%
Gastrointestinal Endoscopy
14%
Endoscopy
14%
Surgical Ward
14%
Instrument Sterilization
14%
Disease Control
14%
Drug Resistance
11%
Confidence Interval
11%
Drug Therapy
11%
Disease
9%
Norfloxacin
9%
Panton Valentine Leukocidin
9%
Tetracycline
9%
Erythromycin
9%
Fusidic Acid
9%
Cotrimoxazole
9%
Infection Control
9%
Antibiotic Resistance
9%
Table Salt
9%
Cefuroxime
9%
Health Practitioner
9%
Antimicrobial Stewardship
9%
Cetylpyridinium Salt
9%
Neonate
9%
Adolescent
9%
Cephalosporin
9%
Ceftriaxone
9%
Nitroimidazole Derivative
9%
Gentamicin
9%
Beta Lactam
9%
Medicine and Dentistry
Surgical Infection
86%
Mycobacterium ulcerans
61%
Buruli Ulcer
60%
Prevalence
33%
Prospective Cohort Study
31%
Digestive System Surgery
28%
Operating Room
28%
Gram-Negative Bacteria
28%
Hospital Infection
28%
Diagnosis
28%
Streptomycin
28%
Rifampicin
28%
Acid Fast Bacterium
22%
Phenol
22%
Ammonium Sulfate
22%
Escherichia coli
19%
Wound
16%
Disease
14%
Low and Middle Income Countries
13%
Infection
13%
Staphylococcus Aureus
11%
Pseudomonas aeruginosa
11%
Antibiogram
10%
Antibiotic Therapy
10%
Cetylpyridinium Salt
9%
Table Salt
9%
Surgery
9%
Surveillance System
6%
Acinetobacter Baumannii
5%
Meropenem
5%
Penicillinase
5%
Cefotaxime
5%
Cohort Analysis
5%
Meticillin
5%
Bright Field Microscopy
5%
Hypochlorite Sodium
5%
Multidrug Resistance
5%
Klebsiella pneumoniae
5%
Antibiotic Prophylaxis
5%
Matrix-Assisted Laser Desorption-Ionization
5%
Rural Health
5%
Laboratory Test
5%
Polymerase Chain Reaction
5%
Emergency Care
5%